Objectively tracking lesions in dermatology clinical trials
White Paper
Mar 04, 2019
There is an increasing need for objectivity in mapping and analyzing of lesions to create confidence in trial findings, reproducibility and translation to clinical practice for dermatology sponsors, regulators and clinicians. This paper examines evolving diagnostic practices coupled with advancing technology and their application to reduce subjectivity in dermatology clinical trials.

Learning Objectives:
  • Learn about the challenges for objective diagnosis and evaluation of patient lesions in clinical practice and trials
  • Review current tools and scoring available to measure dermatological lesions
  • Understand the consideration of the new technologies when developing dermatology trial protocols
Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Call Us

We are pleased to speak with you during our standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.